Atlas Trials

Curcumin Supplementation as an Add on Treatment for Patients With Inflammatory Bowel Diseases Treated With Vedolizumab

Clinical trial NCT03500653 · UNKNOWN

Trial details

NCT number
NCT03500653
Sponsor
Henit Yanai
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Inflammatory Bowel Diseases
Start date
2020-06-09
Primary completion
2021-12-01
Enrollment
100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.